in COBENFY
Pronunciation: zan-OE-me-leen


What it isM1 and M4 muscarinic agonist, given with trospium; schizophrenia.
Why this oneIt is the first antipsychotic in decades that does not block D2, so there is no extrapyramidal or prolactin effect.
What limits itPeripheral cholinergic effects — nausea, vomiting, sweating — which is exactly why trospium is co-formulated.
NO BOXED WARNINGS
Principal riskPeripheral cholinergic effects — nausea, vomiting, sweating — which is exactly why trospium is c
Defining liabilityPeripheral cholinergic adverse effects and syncope
Open Xanomeline in the interactive console ↗
